Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 13/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | LPL | P06858 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.35 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.35 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.35 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.35 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22146594 | 0.95 | RAPGEF4 (0.45) | RAPGEF4FFAR4CA2LPLLIPG | |
| SCHEMBL7458255 | 0.93 | RAPGEF4 (0.37) | RAPGEF4FFAR4CA2LPLLIPG | |
| SCHEMBL85808 | 0.93 | RAPGEF4 (0.37) | RAPGEF4FFAR4CA2LPLLIPG | |
| SCHEMBL14804397 | 0.90 | RAPGEF4 (0.45) | RAPGEF4FFAR4CA2LPLLIPG | |
| SCHEMBL23150833 | 0.89 | FFAR4 (0.44) | RAPGEF4FFAR4ORAI1ORAI2ORAI3 | |
| SCHEMBL16051086 | 0.89 | ACHE (0.42) | RAPGEF4TDP1 | |
| SCHEMBL7458913 | 0.89 | FFAR4 (0.43) | RAPGEF4FFAR4ORAI1ORAI2ORAI3 | |
| SCHEMBL10100950 | 0.89 | ESR1 (0.36) | RAPGEF4FFAR4PSMB5 | |
| SCHEMBL5907929 | 0.89 | RAPGEF4 (0.50) | RAPGEF4FFAR4CA2CYP2A6 | |
| SCHEMBL17866557 | 0.89 | FFAR4 (0.44) | RAPGEF4FFAR4ORAI1ORAI2ORAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3666851-A1 | LIGHT-ACCUMULATING COMPOSITION, LIGHT-ACCUMULATING ELEMENT AND WAVELENGTH CONTROL METHOD | Okinawa Institute of Science and Technology School Corporation (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20200165516-A1 | LONG-PERSISTENT LUMINESCENT COMPOSITION, LONG-PERSISTENT LUMINESCENT DEVICE AND WAVELENGTH CONTROL METHOD | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2020-05-28 | — | — | US | disclosed |
| WO-2019189045-A1 | PHOSPHORESCENT SUBSTANCE AND PHOSPHORESCENT ELEMENT | 国立大学法人九州大学 | 2019-10-03 | — | — | WO | disclosed |
| EP-2243177-B1 | PHOSPHORESCENT OLED HAVING DOUBLE HOLE-BLOCKING LAYERS | GLOBAL OLED TECHNOLOGY LLC (US) | 2019-05-15 | — | — | EP | disclosed |
| EP-2396801-B1 | OLED DEVICE WITH FLUORANTHENE-MACROCYCLIC MATERIALS | GLOBAL OLED TECHNOLOGY LLC (US) | 2018-05-23 | — | — | EP | disclosed |
| EP-2232612-B1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | GLOBAL OLED TECHNOLOGY LLC (US) | 2017-02-08 | — | — | EP | disclosed |
| US-8900722-B2 | OLED device employing alkali metal cluster compounds | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-8900722-B2 | OLED device employing alkali metal cluster compounds | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-12-02 | — | — | US | disclosed |
| EP-2218121-B1 | OLED DEVICE WITH FLUORANTHENE ELECTRON TRANSPORT MATERIALS | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-11-26 | — | — | EP | disclosed |
| US-8431242-B2 | OLED device with certain fluoranthene host | GLOBAL OLED TECHNOLOGY, LLC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-7279603-B2 | Boron and aluminum compounds in electronic components | MERCK PATENT GMBH (DE) | 2007-10-09 | — | — | US | disclosed |
| US-20060241321-A1 | Use of boron and aluminium compounds in electronic components | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-10-26 | — | — | US | disclosed |
| US-7060369-B2 | Use of boron and aluminum compounds in electronic components | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-06-13 | — | — | US | disclosed |
| US-20040058194-A1 | Use of boron and aluminium compounds in electronic components | MERCK PATENT GMBH (DE) | 2004-03-25 | — | — | US | disclosed |
| EP-1217668-A1 | Use of boron and aluminium compounds in electronic devices | Covion Organic Semiconductors GmbH (DE) | 2002-06-26 | — | — | EP | disclosed |
| EP-0775706-B1 | Borates photoinitiators from polyboranes | CIBA SC HOLDING AG (CH) | 2002-06-05 | — | — | EP | disclosed |
| EP-1203999-A2 | Photoinitiator comprising a borane and an electron donating compound | Ciba SC Holding AG (CH) | 2002-05-08 | — | — | EP | disclosed |
| US-6057078-A | PHOTOGRAPHY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| US-5807905-A | POLYMERIZATION OF UNSATURATED COMPOUNDS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-15 | — | — | US | disclosed |
| EP-0775706-A2 | Borates photoinitiators from polyboranes | Ciba SC Holding AG (CH) | 1997-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241321-A1 | Use of boron and aluminium compounds in electronic components | SLCO4C1, SLC43A3, OSBP2 | RAPGEF4 659/4885FFAR4 3398/4885CA2 1380/4885 |
| US-20040058194-A1 | Use of boron and aluminium compounds in electronic components | SLCO4C1, SLC43A3, OSBP2 | RAPGEF4 659/4885FFAR4 3398/4885CA2 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.